Quarterly Result16 Jan 2026, 06:22 pm
JB Pharma Reports 11% Revenue Growth to INR 1065 Crores in Q3 FY26
AI Summary
JB Chemicals & Pharmaceuticals Ltd (JB Pharma) announced its financial results for the quarter ended 31st December 2025. The company recorded a revenue of INR 1,065 crores, registering a growth of 11% from INR 963 crores in Q3 FY25. Operating EBITDA increased by 13% to INR 305 crores and Net Profit rose by 22% to INR 198 crores.
Key Highlights
- Revenue growth of 11% to INR 1065 crores
- Operating EBITDA increased by 13% to INR 305 crores
- Net Profit increases by 22% to INR 198 crores
- Domestic formulations business outperformed the Indian pharmaceutical market
- International formulations business recorded strong growth in several key markets